Print

Conference program

The conference program includes podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers are international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe. 

Program schedule overview

Wednesday, July 18 – afternoon registration hours (Attendees may also check in at the registration desk the following morning.)
Thursday, July 19 – full day of programming
Friday, July 20 – full day of programming
Saturday, July 21 – morning programming

Program Agenda

DAY 1 (Wednesday, July 18):

16.00-19.00: Registration

DAY 2 (Thursday, July 19):

08.00-09.00: Registration

09.00-10.30 Session 1: Global Ocular Oncology
Chairs: David Wilson, MD (ARVO) + André Valente, PhD (Champalimaud Foundation)

09.00-09.25:
Brenda Gallie, MD, FRCSC (SickKids Hospital & University of Toronto, Canada)
"Retinoblastoma can be a Zero Death Cancer"

09.25-09.50:
Rubens Belfort Neto, MD, PhD (Federal University of São Paulo, Brazil)
"Brazilian Model for Addressing Gaps in Access to Ocular Oncology"

09.50-10.15:
Junyang Zhao, MD, MsD (Beijing Childrens Hospital & Capital Medical University, China)
"Coordinating Care for Ocular Tumors Across a Large Population Base: Management of
retinoblastoma in China"

10.15-10.30:
Panel discussion on global oncology, led by David Wilson, MD w/ Gallie, Belfort, Zhao,
Kaliki and Desjardins

10.30-11.00 Morning Tea Break

11.00-13.00 Session 2: Opening/Plenary Session
Chaired by conference organizers: Joan O'Brien, MD & Justine Smith, FRANZCO, PhD (ARVO) and António Parreira, MD, PhD (Champalimaud Foundation)

11.00-11.05: Welcome by conference organizers with introduction of opening speakers

11.05-11.30: Opening of the meeting and introduction to the Champalimaud Centre for
the Unknown Ms. Leonor Beleza, President (Champalimaud Foundation) and Lisbon by Dr. Jose Cunha-Vaz (University of Coimbra) and Ocular Oncology by Dr. Martine Jager (ISOO President).

11.30-11.35: Introduction of opening plenary speaker

11.35-12.20: Opening plenary lecture delivered by Bettina Ryll, MD, PhD (Melanoma Patient Network Europe)
"The Patient of the Future: A European Advocacy Perspective"

12.20-15.00 LUNCH/Networking
+ Tours of Champalimaud Centre for the Unknown (in groups)

15.00-16.30 Poster Session 1: Basic Science Research
+ Afternoon Tea from 16.00-16.30

16.30-18.00 Session 3: Basic Science Research I
Chairs: Hans Grossniklaus, MD (ARVO), Cristina João, MD, PhD (Champalimaud
Foundation)

16.30-16.55: Eduardo Moreno, MD, PhD (Champalimaud Foundation)
"Cell Competition and Cancer"

16.55-17.20: Steffen Heegaard, MD, PhD (University of Copenhagen, Denmark)
"Basic Mechanisms of Conjunctival and Orbital Lymphoma"

17.20-17.45: Sarah Coupland, MBBS, PhD (Royal Liverpool Hospital, United Kingdom)
"Basic Mechanisms of Intraocular Lymphoma"

17.45-18.00: Free paper selected from abstracts
"Aqueous Humor Genomics Predicts Eye Salvage in Retinoblastoma"
Jesse Berry, MD

18.00-19.30 Cocktail Reception

DAY 3 (Friday, July 20):

09.00-10.30 Session 4: Basic Science Research II
Chairs: Sarah Coupland, MBBS, PhD (ARVO), Christa Rhiner, PhD (Champalimaud
Foundation)

09.00-09.25: Bruce Ksander (Harvard University, United States)
"Pathogenesis of Ocular (conjunctival and uveal) Melanoma"

09.25-09.50: Martine Jager, MD, PhD (Leiden University, The Netherlands)
"Immunology of Ocular (conjunctival and uveal) Melanoma"

09.50-10.15: Hans Grossniklaus, MD (Emory University, United States)
"Metastatic Mechanisms of Uveal Melanoma – the Zimmerman Effect"

10.15-10.30: Free paper selected from abstracts
"Uveal melanoma and BAP1 tumour predisposition syndrome"
Cindy Chau, MD

10.30-11.00 Morning Tea Break

11.00-12.30 Session 5: Clinical Research I
Chairs: Arun Singh, MD (ARVO), Celso Matos, MD (Champalimaud Foundation)

11.00-11.25: Fatima Cardoso, MD (Champalimaud Foundation)
"The Role of Genomics in Breast Cancer Management"

11.25-11.50: Dan Gombos, MD (University of Texas, United States)
"Treatment of Primary and Metastatic Uveal Melanoma"

11.50-12.15: Swathi Kaliki, MD (LV Prasad Eye Institute, India)
"Latest in the Management of Ocular Surface Squamous Neoplasia"

12.15-12.30: Panel discussion on management of ocular surface tumors led by Arun Singh, MD, with Gombos, Kaliki, Belfort, Heegard and Cardoso

12.30-14.30 LUNCH/Networking

14.30-16.00 Poster Session 2: Clinical Research
+ Afternoon Tea from 15.30-16.00

16.00-17.30 Session 6: Clinical Research II
Chairs: Dan Gombos, MD (ARVO), Durval Costa, MD, PhD (Champalimaud Foundation)

16.00-16.25: Carlos Carvalho, MD (Champalimaud Foundation)
"Cancer and Organ Preservation – old paradigms and new challenges?"

16.25-16.50: Jasmine Francis (Memorial Sloan Kettering Cancer Center, United States)
"Current Treatment of Retinoblastoma: Ophthalmic artery chemotherapy and intravitreal chemotherapy"

16.50-17.15: Jacob Pe'er (Hadassah - Hebrew University Medical Center, Israel)
"Current Management of Primary Vitreo-Retinal Lymphoma"

17.15-17.30: Panel discussion on management of intraocular tumors led by Dan
Gombos, MD, with Francis, Pe'er, Pulido, Zhao and Carvalho

DAY 4 (Saturday, July 21):

8.30-10.30 Session 7: Looking Ahead
Chairs: Brenda Gallie, MD, FRCSC, Thiago Carvalho, PhD (Champalimaud Foundation)

08.30-08.55: Markus Maeurer, MD, PhD (Champalimaud Foundation)
"Immune Surgery: A possible approach for patients with uveal melanoma?"

08.55-09.20: Arun Singh, MD (Cleveland Clinic, United States)
"Complications of Current Oncologic Treatments"

09.20-9.45: Jose Pulido, MD (Mayo Clinic, United States)
"The Hamartia of Check-Point Inhibitors and the Emergence of Viroimmunotherapy for Uveal Melanomas"

9.45-10.10: Laurence Desjardins (Institut Curie, France)
"The Future in Management of Ocular Tumors: Multicenter initiatives, novel diagnostics and therapies"

10.10-10.20: Free paper selected from abstracts
"Evaluation of Optical Coherence Tomography Findings in Central Nervous System Lymphoma with or without Ocular Involvement"
Yasir Sepah, MD

10.20-10.30: Free paper selected from abstracts
"Changes in tumor microenvironment in response to intra-tumoral oncolytic virus treatment in metastatic uveal melanoma"
Sapna Patel, MD

10.30-11.00 Morning Tea Break

11.00-12.00 Session 8: Closing/Plenary Session
Chaired by conference organizers: David Wilson, MD  & Jacob Pe'er, MD (ARVO) & António Parreira, MD, PhD (Champalimaud Foundation)

11.00-11.05: Introduction of closing plenary speaker

11.05-11.50: Closing plenary lecture delivered by Richard Carvajal, MD (Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center)
"A New Optimism: Uveal Melanoma in the Era of Precision Oncology and Immuno-Oncology

11.50-12.00: Closing remarks

Special thanks to the event sponsor

Delcath Systems